If you're seeing this message, that means
JavaScript has been disabled on your browser
, please
enable JS
to make this app work.
No tags found
Companies
No companies found
Advanced Search
Newsfeed
Alerts
Saved Lists
Sign Up for Free
Login
Update this Profile
Get Updates
5
Followers on Owler
Goldfinch Bio
is a biotechnology company that develops and commercializes gene therapies for the treatment of kidney diseases...
Read more
Overview
Competitors
Funding
News & Insights
Goldfinch Bio
is a biotechnology company that develops and commercializes gene therapies for the treatment of kidney diseases...
Read more
President & CEO
Anthony Johnson
CEO Approval Rating
94/100
Weigh In
2016
Cambridge
Massachusetts
Greater Boston
Private
Pharmaceuticals & Biotechnology
Biotechnology
2836
2834
NAICS listing
http://goldfinchbio.com/
Est. Annual Revenue
$100K-5.0M
Agree?
Yes
No
Est. Employees
25-100
Agree?
Yes
No
Funding
$155M
News
Latest News
Feb 03, 2023
Pharamceutical Technology
Goldfinch Bio: Karuna signs license deal with Goldfinch Bio for TRPC4/5 candidates
Aug 02, 2022
Business Wire
Press Release: Goldfinch Bio : Goldfinch Bio to Present at the 2022 Wedbush PacGrow Healthcare Virtual Conference
Jul 07, 2022
Portada
Goldfinch Bio: Goldfinch Bio Announces Publication in Science Advances on the Validation of Human Derived Organoids as a Predictable and Translatable Preclinical Model in Kidney Disease for the Evaluation of Therapeutic Drug Candidates
May 31, 2022
Business Wire
Press Release: Goldfinch Bio : Goldfinch Bio to Present Initial Data from Phase 1 Clinical Trial of GFB-024 at American Diabetes Association 82nd Scientific Sessions and Endocrine Society's Annual Meeting, ENDO 2022
Mar 22, 2022
Business Wire
Press Release: Goldfinch Bio : Goldfinch Bio to Host Virtual Event on Unmet Need in Focal Segmental Glomerulosclerosis (FSGS) and GFB-887 as a Novel Kidney Precision Medicine Candidate
Feb 28, 2022
FirstWord Pharma
Goldfinch Bio: Goldfinch Bio Announces Positive Preliminary Data from Phase 2 Clinical Trial Evaluating GFB-887 as a Precision Medicine for Patients with Focal Segmental Glomerular Sclerosis (FSGS)
Feb 23, 2022
Business Wire
Press Release: Goldfinch Bio : Goldfinch Bio to Participate in Upcoming Industry Conferences
Dec 06, 2021
firstword pharma
Goldfinch Bio: Goldfinch Bio Appoints Jeff W. Jacobs as CSO
Nov 08, 2021
Business Wire
Press Release: Goldfinch Bio : Goldfinch Bio Showcases Biology, Genetic and Clinical Programs at ASN Kidney Week Demonstrating Leadership in Precision Medicines for Kidney Diseases
Oct 15, 2021
Business Wire
Press Release: Goldfinch Bio : Goldfinch Bio Announces Upcoming Presentations at American Society of Human Genetics (ASHG) 2021 Meeting and American Society of Nephrology's (ASN) Kidney Week 2021
Follow and Get Alerts
Goldfinch Bio Competitors
1
Follow
2
Follow
3
Follow
4
Follow
5
Follow
6
Follow
7
Follow
8
Follow
9
Follow
10
Follow
Unlock 11 + competitors
Trending Companies